Abstract
Deposition of amyloid β peptide in human brain in the form of senile plaques is a neuropathological hallmark of Alzheimer’s disease (AD). Levels of a phospholipid breakdown product, glycerophosphocholine (GPC), also increase in AD brain. The effect of GPC on amyloid β(1–40) peptide (Aβ) aggregation in PBS buffer was investigated by circular dichroism and fluoresence spectroscopy; interactions of Aβ and GPC with the intact erythrocyte membrane was examined by fluoresence spectroscopy. Fluorescamine labeled Aβ studies indicate GPC enhances Aβ aggregation. CD spectroscopy reveals that Aβ in the presence of GPC adopts 14% more β-sheet structure than does Aβ alone. Fluorescamine anisotropy measurements show that GPC and Aβ interact in the phospholipid head-group region of the erythrocyte membrane. In summary, both soluble Aβ and GPC insert into the phospholipid head-group region of the membrane where they interact leading to β-sheet formation in soluble Aβ which enhances Aβ aggregation.
Similar content being viewed by others
References
L. Fratiglioni L. J. Launer K. Andersen M. M. Breteler J. R. Copeland J. F. Dartigues A. Lobo J. Martinez-Lage H. Soininen A. Hofman (2000) ArticleTitleIncidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts Neurologic Diseases in the Elderly Research Group. Neurology. 54 S10–S15
H. Yamaguchi M. L. Maat-Schieman S. G. Van Duinen F. A. Prins P. Neeskens R. Natte R. A. Roos (2000) ArticleTitleAmyloid beta protein (Abeta) starts to deposit as plasma membrane-bound form in diffuse plaques of brains from hereditary cerebral hemorrhage with amyloidosis-Dutch type, Alzheimer disease and nondemented aged subjects J. Neuropathol. Exp. Neurol. 59 723–732
C. J. Pike A. J. Walencewicz C. G. Glabe C. W. Cotman (1991) ArticleTitleAggregation-related toxicity of synthetic beta-amyloid protein in hippocampal cultures Eur. J. Pharmacol. 207 367–368
J. McLaurin A. Chakrabartty (1996) ArticleTitleMembrane disruption by Alzheimer beta-amyloid peptides mediated through specific binding to either phospholipids or gangliosides Implications for neurotoxicity. J. Biol. Chem. 96 26482–26489
N. A. Avdulov S. V. Chochina U. Igbavboa E. O. O’Hare F. Schroeder J. P. Cleary W. G. Wood (1997) ArticleTitleAmyloid beta-peptides increase annular and bulk fluidity and induce lipid peroxidation in brain synaptic plasma membranes J. Neurochem. 97 2086–2091
J.W. Pettegrew N.J. Minshew M.M. Cohen S.J. Kopp T. Glonek (1984) ArticleTitleP-31 NMR changes in Alzheimer’s and Huntington’s disease brain Neurology 34 281
J. W. Pettegrew S. J. Kopp N. J. Minshew T. Glonek J. M. Feliksik J. P. Tow M. M. Cohen (1987) ArticleTitleP nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: Preliminary observations J. Neuropathol. Exp. Neurol. 46 419–430
J. W. Pettegrew J. Moossy G. Withers D. McKeag K. Panchalingam (1988) ArticleTitle31P nuclear magnetic resonance study of the brain in Alzheimer’s disease J. Neuropathol. Exp. Neurol. 47 235–248
J. W. Pettegrew K. Panchalingam J. Moossy J. Martinez G. Rao F. Boller (1988) ArticleTitleCorrelation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer’s disease Arch. Neurol. 45 1093–1096
M. Barany Y.-C. Chang C. Arus T. Rustan W.H. Frey (1985) ArticleTitleIncreased glycerol-3-phosphorylcholine in post-mortem Alzheimer’s brain (letter). Lancet 1 517
C. D. Smith L. G. Gallenstein W. J. Layton R. J. Kryscio W. R. Markesbery (1993) ArticleTitle31P magnetic resonance spectroscopy in Alzheimer’s and Pick’s disease Neurobiol. Aging 14 85–92
J. W. Pettegrew K. Panchalingam R. L. Hamilton R. J. McClure (2001) ArticleTitleBrain membrane phospholipid alterations in Alzheimer’s disease Neurochem. Res. 26 771–782
J. W. Pettegrew K. Panchalingam W. E. Klunk R. J. McClure L. R. Muenz (1994) ArticleTitleAlterations of cerebral metabolism in probable Alzheimer’s disease: A preliminary study Neurobiol. Aging 15 117–132
R. M. Nitsch J. K. Blusztajn A. G. Pittas B. E. Slack J. H. Growdon R. J. Wurtman (1992) ArticleTitleEvidence for a membrane defect in Alzheimer disease brain Proc. Natl. Acad. Sci. USA 89 1671–1675
W. E. Klunk C. J. Xu R. J. McClure K. Panchalingam J. A. Stanley J. W. Pettegrew (1997) ArticleTitleAggregation of beta-amyloid peptide is promoted by membrane phospholipid metabolites elevated in Alzheimer’s disease brain J. Neurochem. 69 266–272
J. W. Pettegrew N. J. Minshew D. Spiker M. Tretta S. Strychor D. McKeag L. R. Munez G. M. Miller D. Carbone R. J. McClure (1993) ArticleTitleAlterations in membrane molecular dynamics in erythrocytes of patients with affective illness Depression 1 88–100
A. Lobley B.A. Wallace (2001) ArticleTitleDICHROWEB: A website for the analysis of protein secondary structure from circular dichroism spectra. Biophys. J. 80 373a
A. Lobley L. Whitmore B. A. Wallace (2002) ArticleTitleDICHROWEB: An interactive website for the analysis of protein secondary structure from circular dichroism spectra Bioinformatics 18 211–212
B.A. Wallace R.W. Janes A. Orry (2001) ArticleTitleSecondary structure information content on the VUV region of synchrotron radiation circular dichroism (SRCD) spectra. Biophys. J. 80 28a
J. W. Pettegrew N. J. Minshew J. S. Nichols (1982) ArticleTitleFluorescence probes specific for the plasma membrane of intact human erythrocytes and lymphocytes Life Sci. 30 1101–1105
M. P. Mattson M. Sherman (2003) ArticleTitlePerturbed signal transduction in neurodegenerative disorders involving aberrant protein aggregation Neuromol. Med. 4 109–131
R. Jayakumar J. W. Kusiak F. J. Chrest A. A. Demehin J. Murali R. P. Wersto E. Nagababu L. Ravi J.M. Rifkind (2003) ArticleTitleRed cell perturbations by amyloid beta-protein Biochim. Biophys. Acta. 1622 20–28
W. E. Muller S. Koch A. Eckert H. Hartmann K. Scheuer (1995) ArticleTitlebeta-Amyloid peptide decreases membrane fluidity Brain Res. 674 133–136
V. P. Chauhan A. Chauhan J. Wegiel (2001) ArticleTitleFibrillar amyloid beta-protein forms a membrane-like hydrophobic domain Neuroreport 12 587–590
W. E. Muller C. Kirsch G. P. Eckert (2001) ArticleTitleMembrane-disordering effects of beta-amyloid peptides Biochem. Soc. Trans. 29 617–623
J.T. Jarrett P. T. Lansbury SuffixJr. (1992) ArticleTitleAmyloid fibril formation requires a chemically discriminating nucleation event: Studies of an amyloidogenic sequence from the bacterial protein OsmB Biochemistry 31 12345–12352
H. LeVine (1993) ArticleTitleThioflavine T interaction with synthetic Alzheimer’s disease beta-amyloid peptides: Detection of amyloid aggregation in solution Protein Sci. 2 404–410
A. Kakio S. Nishimoto K. Yanagisawa Y. Kozutsumi K. Matsuzaki (2002) ArticleTitleInteractions of amyloid beta-protein with various gangliosides in raft-like membranes: Importance of GM1 ganglioside-bound form as an endogenous seed for Alzheimer amyloid Biochemistry 41 7385–7390
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mandal, P.K., McClure, R.J. & Pettegrew, J.W. Interactions of Aβ(1–40) with Glycerophosphocholine and Intact Erythrocyte Membranes: Fluorescence and Circular Dichroism Studies. Neurochem Res 29, 2273–2279 (2004). https://doi.org/10.1007/s11064-004-7036-0
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s11064-004-7036-0